title: Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
authors.affiliation: The Botnar Research Centre & Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Institute of Musculoskeletal Sciences, Oxford University, Oxford, OX3 7LD, UK, Michael.Pazianas@ndorms.ox.ac.uk.
authors.forename: M
authors.initials: M
authors.lastname: Pazianas
authors.forename: B
authors.initials: B
authors.lastname: Abrahamsen
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates